Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for PTSD Symptoms
NCT03077919Completed
- Sponsor
- RTI International
- Start
- May 2016
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Randomised, double-blind trial of ropivacaine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by RTI International. Primary endpoint: Clinician Administered PTSD Scale for DSM-5 at 8 weeks. Started May 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03077919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077919.